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Activation of MMP-9 by human lung epithelial cells in response to the cystic
fibrosis-associated pathogen Burkholderia cenocepacia reduced wound healing
in vitro
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Wright C, Pilkington R, Callaghan M, McClean S. Activation of
MMP-9 by human lung epithelial cells in response to the cystic fibrosis-
associated pathogen Burkholderia cenocepacia reduced wound healing in
vitro. Am J Physiol Lung Cell Mol Physiol 301: L575–L586, 2011. First
published July 8, 2011; doi:10.1152/ajplung.00226.2010.—Burkholderia
cepacia complex is a group of bacterial pathogens that cause oppor-
tunistic infections in cystic fibrosis (CF). The most virulent of these is
Burkholderia cenocepacia. Matrix metalloproteinases (MMPs) are
upregulated in CF patients. The aim of this work was to examine the
role of MMPs in the pathogenesis of B. cepacia complex, which has
not been explored to date. Real-time PCR analysis showed that B.
cenocepacia infection upregulated MMP-2 and MMP-9 genes in the
CF lung cell line CFBE41o within 1 h, whereas MMP-2, -7, and -9
genes were upregulated in the non-CF lung cell line 16HBE14o.
Conditioned media from both cell lines showed increased MMP-9
activation following B. cenocepacia infection. Conditioned media
from B. cenocepacia-infected cells significantly reduced the rate of
wound healing in confluent lung epithelia (P  0.05), in contrast to
conditioned media from Pseudomonas aeruginosa-infected cells,
which showed predominant MMP-2 activation. Treatment of control
conditioned media from both cell lines with the MMP activator
4-aminophenylmercuric acetate (APMA) also resulted in clear acti-
vation of MMP-9 and to a much lesser extent MMP-2. APMA
treatment of control media also delayed the repair of wound healing in
confluent epithelial cells. Furthermore, specific inhibition of MMP-9
in medium from cells exposed to B. cenocepacia completely reversed
the delay in wound repair. These data suggest that MMP-9 plays a role
in the reduced epithelial repair observed in response to B. cenocepacia
infection and that its activation following B. cenocepacia infection
contributes to the pathogenesis of this virulent pathogen.
microbial pathogenesis; Burkholderia cepacia complex; matrix met-
alloproteinases; epithelial wound repair
BURKHOLDERIA CEPACIA COMPLEX is an opportunistic bacterial
pathogen that chronically colonizes the lungs of patients with
either cystic fibrosis (CF) or chronic granulomatous disease
(CGD) and causes life-threatening infections in both popula-
tions (31, 32, 44). It is a group of 17 related species that are
inherently resistant to antibiotic treatment (48, 49). CF is a
genetically inherited disorder caused by mutations in the cystic
fibrosis transmembrane regulator (CFTR), a chloride channel.
A common feature of CF is chronic opportunistic respiratory
infections that patients acquire throughout their lives, resulting
in a continuous cycle of infection and inflammation that grad-
ually damages the lungs, thereby reducing lung function. Al-
though Pseudomonas aeruginosa is the most commonly ac-
quired pathogen in CF patients, other pathogens, including B.
cepacia complex, can also colonize and contribute to lung
inflammation and damage (31). Although strict segregation
measures have reduced the incidence of B. cepacia complex
infection, two species, B. cenocepacia and B. multivorans, can
be acquired from the environment, and patient-to-patient trans-
missibility is still an issue (3, 4, 31, 37). Of these, B. cenoce-
pacia is particularly virulent. Jones et al. (22) have demon-
strated that CF patients with B. cenocepacia infection had a
shorter survival time than those with P. aeruginosa or B.
multivorans infection.
Matrix metalloproteinases (MMPs) are a group of related but
distinct enzymes that regulate various inflammatory and repair
processes. They are either secreted or anchored to the cell
surface and therefore their activity is directed against mem-
brane proteins or extracellular proteins, including inflamma-
tory mediators (40). Many MMPs, such as collagenase-1 and -3
(MMP-1 and MMP-13, respectively), stromelysins-1, -2, -3
(MMPs-3, -10, and -11), and gelatinase-B (MMP-9), are not
expressed in normal healthy resting tissues or are only barely
detectable (39). Matrilysin (MMP-7) is expressed on the
wounded edge or within injured epithelial cells of the lung and
is required for reepithelialization, but it is also expressed in the
noninjured and noninflamed epithelium in adult tissues (40). In
vitro and ex vivo studies have shown that MMP-9 also plays a
role in reepithelization in the lung (29). Dysregulation of
metalloproteinases has also been associated with inflammation
and tissue damage (11, 39, 40). MMPs are also upregulated in
the CF lung (23, 30).
The induction and activation of MMP-7 in mucosal epithelia
is highly sensitive to the presence of virulent bacteria, such as
P. aeruginosa, but not Staphylococcus aureus, Haemophilus
influenzae, or Klebsiella pneumoniae. The induced expression
of MMP-7 in Calu-3 cells was attributed to P. aeruginosa
flagellin (30). P. aeruginosa virulence factors, most likely
elastase, have also been shown to overactivate host MMP-2
and prevent the formation of tight junctions during repair (7).
MMP-7 has been shown to degrade E-cadherin (35), whereas
MMP-9 plays a role in claudin turnover (20, 50), suggesting
that host MMPs could play a role in disruption of tight junction
integrity following infection because they are regulated by
cytokines, including IL-13 (28). MMPs have been shown to be
responsible for early dissemination of Mycobacterium tuber-
culosis in mice, and MMP-9 has been shown to play a caus-
ative role in granuloma formation during M. tuberculosis
infection (45). The role of MMPs in the pathogenesis of the CF
pathogen B. cepacia complex has not been explored to date,
and therefore we investigated whether MMP expression plays
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a role in B. cepacia complex host-cell response in lung epithe-
lia.
MATERIALS AND METHODS
Materials. All materials were purchased from Sigma, with the
following exceptions: TRIzol, Superscript III, Taq polymerase and
Ultroser G (Invitrogen), Vitrogen (Nutacon); MMP-9 inhibitor I
(Merck Chemicals), SYBR green PCR Mastermix (Roche), and Fluo-
rokine E human MMP-9 fluorescent assay kit (R&D Systems).
Cell culture. Both human lung epithelial cell lines, 16HBE14o
and CFBE41o, were a generous gift from Dr. Dieter Gruenert,
University of California, San Francisco. The 16HBE14o cells (pas-
sage 2.85 to 2.105) were maintained on Vitrogen/fibronectin-coated
flasks in minimum essential medium (MEM) supplemented with
1% L-glutamine, 1% penicillin-streptomycin, and 10% FBS. (6)
CFBE41o cells (passage 4.85 to 4.105) were derived from a CF
patient that was homozygous negative for the most common CFTR
mutation, F508, and were also maintained on coated flasks in the
same medium, supplemented with 1% nonessential amino acids (15).
Confluent monolayers of 16HBE14o cells were obtained by seeding
at 2  105 cells/ml in 1 ml in 24-well plates for 48 h prior to
zymography. CFBE41o cells were seeded at 1  105 cells/ml in 1
ml. Medium was changed at 24 h and replaced with complete medium
without antibiotics. A confluent monolayer was present at 48 h.
Polarized monolayers were also prepared by seeding 16HBE 14o or
CFBE41o cells at 7  105/cm on coated Transwell polycarbonate
filters. The cells were incubated overnight before removal of the
apical medium, grown for 6 days with an air-liquid interface, and fed
basolaterally on alternate days, with medium in which the FBS was
replaced with 2% Ultroser G (27).
Bacterial infection of lung epithelial cells. The two B. cepacia
complex strains used in this study, Burkholderia cenocepacia strain
(BC7) and Burkholderia multivorans strain (LMG13010), were both
obtained from the Belgian Co-ordinated Collections of Micro-organ-
isms, University of Ghent, Belgium and routinely grown on B.
cepacia-specific agar (18). P. aeruginosa (PAO1) was used as a
reference strain and was obtained from American Type Culture
Collection. Overnight bacterial cultures were grown in Luria-Bertani
broth to an OD600nm of 0.6 and then diluted to a given concentration.
A suspension of 2  107 CFU/ml was made up in MEM and added to
the confluent cultures of lung epithelial cells at a multiplicity of
infection of 50:1. The plate was centrifuged to settle bacteria for 5 min
at 700 g and incubated at 37°C and 5% CO2 for the appropriate time.
Isolation of RNA and cDNA biosynthesis. Following bacterial
infections, medium was removed, cells were directly lysed in TRIzol,
and total RNA was isolated according to manufacturer’s instructions.
An aliquot of 1 g of RNA (A260/280 1.7) was used to synthesize
by cDNA using Superscript III according to the manufacturer’s
instructions.
Expression of MMP genes. Initial studies to explore the effects of
bacteria on transcription of metalloproteinase genes in CFBE41o and
16HBE14o cells were carried out semiquantitatively over a 24-h
period. A selection of MMP genes, MMP- 2, 3, 7, and 9 cDNAs (1 l),
was amplified in a 50-l reaction by reverse transcriptase PCR (RT-
PCR). The primers used were as follows: GAPDH forward 5=-
CCCCTTCATACCCTCACGTA-3=, reverse 5=-ACAAGCTTC-
CCGTTCTCAG-3=; MMP-2 forward 5=-AGGGCACATCCTATGA-
CAGC-3=, reverse 5=-CCTTCTGAGTTCCCACCAAC-3=; MMP-3
forward 5=-TCCGCCTGTCTCAAGATGAT-3=, reverse 5=-CCA-
AAAGTGCCTGTCTTTA-3=; MMP-7 forward 5=-TGTATGGG-
GAACTGCTGACA-3=, reverse 5=-AGACTGCTACCATCCGTCCA-
3=; MMP-9 forward 5=-CAGTCCACCCTTGTGCTCTT-3=, reverse 5=-
AGGGACAGTTGCTTCTGGAG-3=.
PCR was carried out for 35 cycles of denaturation (30 s, 95°C),
annealing (30 s, 58°C), and elongation (45 s, 72°C).
Real-time PCR was carried out by using the same primers as those
for regular PCR together with FastStart Universal SYBR Mastermix
(Roche) according to manufacturer’s instructions at concentrations of
380 nM for MMP primers and 190 nM for GAPDH. The samples were
amplified in triplicate on a 7300 Real-Time PCR System (Applied
Biosystems) as follows: 40 cycles of denaturation (15 s, 95°C) and
annealing/elongation (1 min, 66°C) were carried out. The threshold
cycles (Ct) for each primer set were obtained from triplicate samples
and averaged. The delta Ct was the calculated difference between the
average Ct for the target gene and the average Ct for GAPDH as a
control for total starting RNA quantity. The delta-delta Ct method of
calculation was then used to assess fold change in gene expression
relative to the GAPDH gene.
Gelatin zymography. Gelatin zymography experiments were per-
formed on conditioned media harvested from control untreated cells,
from infected lung epithelial cells as described above, or from
4-aminophenylmercuric acetate (APMA)-treated supernatants to as-
sess the level of MMP-2 and MMP-9 enzyme secreted. Conditioned
media were harvested from cells at appropriate time points posttreat-
ment and stored at 80°C until use. A volume of 20 l of cell-
conditioned medium was mixed with 5 nonreducing Laemlli buffer
(60 mM Tris-Cl, pH 6.8, 2% SDS, 10% glycerol, 0.01% bromophenol
blue) and loaded onto a 10% SDS-PAGE gel containing 0.1% gelatin.
Samples were electrophoresed at 140 V for 90 min and then the gels
were rinsed in distilled water and washed in two changes of 2.5%
Triton-X 100 to remove SDS for 1 h. Gels were then incubated for 24
h in digestion buffer (50 mM Tris pH 8, 0.5 mM CaCl2, 5 M ZnCl2)
at 37°C. Bands were visualized by Coomassie blue staining for 1 h
followed by destaining in methanol-acetic acid-water (1:1:8) for 10
min. Gelatinase activity corresponded to areas of clearance of the
gelatin from the gels. The images were captured on a SynGene G:box
system (SynGene, Cambridge, UK) and the clear bands were analyzed
by SynGene Gene Tools software. The activity of all samples were
normalized by setting the activity of the relevant control to one, and
the data were presented as the fold change in activity.
Determination of active and total MMP-9 secretion. The amount of
total and active MMP-9 secreted was determined by using a Fluoro-
kine E human MMP-9 fluorescent assay kit according to the manu-
facturer’s instructions. Conditioned cell medium (diluted 1:10) or
MMP-9 standard (200 l per well) were added to individual wells
precoated with MMP-9-specific capture antibody, incubated for 2 h,
and washed four times. Total MMP-9 was determined in the presence
of APMA, whereas no activator was added to wells to determine
active MMP-9. The fluorogenic substrate was added for a further 18
h at 37°C and fluorescence generated was measured on a Thermo
Fisher Varioskan Flash spectrophotometer. The MMP-9 activity was
determined by comparison with a standard curve of the log of the
active MMP-9 concentration against the log of the relative fluores-
cence units, determined by regression analysis.
Transepithelial resistance. For tight membrane integrity experi-
ments, 16HBE14o or CFBE41o cells were seeded at 7  105
cells/ml on Transwell filters that were precoated with Vitrogen. The
integrity of the polarized monolayer was determined by measuring
transepithelial electrical resistance (TER) using an epithelial volt-
ohmmeter (World Precision Instruments) and corrected for the resis-
tance value of the cell-free filter. Only polarized monolayers with a
TER of 200 /cm2 over that of cell-free filters were used. TER
values were 510	 100 and 484	 56/cm2 for CFBE41o cells and
16HBE14o cells, respectively. Cells were pretreated with GM6001
(10 M) for 30 min prior to, and during, the period of infection with
bacteria; the TER was measured at regular intervals and compared
with parallel wells exposed to bacterial alone or inhibitor alone.
Wound repair assays. Confluent monolayers of either 16HBE14o
or CFBE41o were cultured as stated above with and without
bacterial infection. Medium was replaced with MEM alone for 24 h.
Conditioned media from uninfected cells were harvested and treated
with 1 mM APMA (Sigma) or DMSO (solvent control) for 16 h at
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37°C with gentle agitation to activate the MMPs released. Condi-
tioned media either from infected cells or following APMA treatment
were either used immediately or stored at 80°C for use in zymog-
raphy. To confirm the role of MMP-9, conditioned media from B.
cenocepacia strain BC7-infected cells were also preincubated with 20
nM MMP-9 inhibitor 1 for 30 min prior to application. Confluent
monolayers were also cultured for wounding. A wound was inflicted
by scraping with a sterile pipette tip across the entire monolayer as
described by Olsen et al. (38). Images of the wounds were captured
via a microscope video eyepiece camera USB at time intervals, and
the monolayers were replaced in the incubator at 37°C and 5% CO2
between imaging. The distance between the cell migration fronts was
measured by using an ocular measurement graticule at five predeter-
mined points along the length of the scrape. The values are presented
as repair of the wound in micrometers.
Statistical analysis. The data changes in transepithelial resistance
and wound healing experiments for individual strains were compared
with one-way ANOVA with Tukey’s posttest for pairwise compari-
sons (Minitab). Two-tailed Student’s t-test (assuming unequal vari-
ances) was used to compare the real-time PCR data of individual
strains relative to the untreated negative control, densitometry analysis
of zymograms, and fluorescence analysis of MMP-9 expression or
activation relative to control cells. A P value of 0.05 was deemed to
be significant in each case.
RESULTS
Semiquantitative analysis of MMP gene expression indi-
cated upregulation of MMP-2 and MMP-9 mRNA. To enable
us to focus on the MMP genes of interest, the expression of
MMP-2, 3, 7, and 9 genes was investigated in two independent
cell lines in response to B. cepacia complex infection or P.
aeruginosa strain PAO1 infection over a 24-h period by semi-
quantitative PCR, initially. Both the 16HBE14o and
CFBE41o cell lines expressed all of the examined genes,
albeit MMP-3 mRNA was expressed at very low levels and
was barely detectable in CFBE41o cells (Fig. 1, A and B).
Semiquantitative reverse transcriptase PCR suggested an up-
regulation of MMP-2 and MMP-9 mRNA at earlier time points
in both of these cell lines, in response to infection with B.
cenocepacia strain BC7, B. multivorans strain LMG13010, and
P. aeruginosa strain PAO1. To confirm the upregulation of
these genes as an early response to infection, the expression of
these two genes was therefore further examined by real-time
PCR at the earliest time point of 1 h only. Although no clear
upregulation of MMP-7 gene expression was observed by PCR
when normalized with GAPDH, previous studies on Calu-3
cells demonstrated MMP-7 upregulation following exposure to
P. aeruginosa strain PAO1 (24); thus this was also included in
further studies.
MMP-2 and MMP-9 mRNA upregulated in lung epithelial
cells in response to B. cepacia complex infection. The apparent
upregulation of MMP-2 and MMP-9 genes in the 16HBE14o
and CFBE41o cell lines in response to exposure to B. cenoce-
pacia strain BC7, B. multivorans strain LMG13010, or P. aerugi-
nosa strain PAO1 was quantitatively examined by real-time PCR
at the early time point of 1 h (Fig. 2). MMP-2 gene expression
was increased within 1 h in both cell lines in response to B.
cepacia complex infection. The B. cenocepacia strain BC7
upregulated MMP-2 gene expression in both 16HBE14o
cells (3-fold, P  0.05) and CFBE41o cells (4-fold, P 
0.01), thus having a somewhat greater effect on CFBE41o
cells than on 16HBE14o cells. Although B. multivorans
strain LMG13010 also upregulated the MMP-2 gene in
16HBE14o cells by 4.6-fold (P  0.01), there was no
statistically significant upregulation in CFBE41o cells, rela-
tive to controls. There was a 2- to 3-fold increase in MMP-7
gene expression in response to both B. cepacia complex strains
and to PAO1, in 16HBE14o cells only. In contrast, there was
no MMP-7 response in CFBE41o cells within 1 h of infec-
tion with any of the three strains examined. B. cenocepacia
BC7 infection also resulted in an upregulation of the MMP-9
gene in both cell lines; however, no alteration in MMP-9 gene
expression was observed in response to B. multivorans strain
LMG13010 or to P. aeruginosa in either cell line. Interest-
ingly, there was no upregulation of any of the three genes
examined in response to P. aeruginosa (PAO1) in CFBE41o
cells was observed at the early 1 h time point, but increased
expression of both MMP-2 mRNA (6-fold) and MMP-7
mRNA (2.8-fold) was observed in 16HBE14o cells (P 
0.01).
MMP-9 is activated following B. cenocepacia infection. The
secreted levels of MMP-2 and MMP-9 were examined by gelatin
zymography of conditioned media at 24 and 48 h (Fig. 3). There
was a clear activation of MMP-9 in the presence of B. ceno-
cepacia strain BC7 over 48 h, in the conditioned medium from
both the 16HBE14o cells (3-fold) and CFBE41o cells
(2-fold) (Fig. 3A, P  0.05). This activation was confirmed by
MMP-9-specific fluorometric assay (Fig. 3B), which indicated
that a 4-fold and 3.8-fold increase in MMP-9 activity was
Fig. 1. Upregulation of matrix metalloproteinase (MMP)-2 and MMP-9 genes
in response to Burkholderia cepacia complex and Pseudomonas aeruginosa
infection by semiquantitative RT-PCR. Confluent monolayers of 16HBE14o
cells (A) and CFBE41o cells (B) were exposed to bacteria (multiplicity of
infection 50:1) for 1, 2, 4, or 24 h and the expression of MMP-2, MMP-3,
MMP-7, and MMP-9 mRNA was determined by semiquantitative RT-PCR.
Upregulation of both MMP-2 and MMP-9 genes is apparent at 2 h in response
to B. cepacia complex. No clear upregulation of the MMP-7 gene was
observed. Images are representative gels from 2 independent experiments. neg,
Negative; pos, positive, CTRL, control cells treated with bacteria-free medium;
BC7, B. cenocepacia strain; LMG13010, B. multivorans strain; PAO1, P.
aeruginosa strain.
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achieved in 16HBE14o and CFBE41o cells, respectively
(P  0.05). Zymography showed an upregulation of MMP-9
by 1.7-fold 48 h following infection of 16HBE14ocells with
B. multivorans strain LMG13010 (Fig. 3A), but which was not
apparent in CFBE41o cells. Despite the lack of apparent
activation of MMP-9 in CFBE41-cells by zymography, quan-
titation of MMP-9 activity demonstrated a 2.0-fold and 2.4-
fold increase in MMP-9 activity in 16HBE14o and
CFBE41o cells (P  0.05) following 48-h exposure to B.
multivorans strain LMG13010. The difference in zymography
and fluorometric assay may be due to the fact that zymography
underestimated the relatively weak MMP-9 activation by B.
multivorans LMG13010 in CFBE cells. No activation of pro-
MMP-2 was observed for either B. cepacia complex strain. In
comparison, much more MMP activation was evident follow-
ing infection of 16HBE41o cells with PAO1 (Fig. 3C). When
the conditioned medium from PAO1 was applied without
dilution to zymography gels, extensive gelatinase activation
was observed as seen by a large smear of gelatin degradation
(Fig. 3C), and it was difficult to determine which gelatinase
was activated. However, dilution of the conditioned medium
to 1:100 and below showed that the predominant MMP
activated following PAO1 infection was MMP-2 in
16HBE14o cells. Comparable studies indicated that
CFBE41o cells also secreted high levels of MMP-2 in
response to PAO1 (Fig. 3D).
Secretion of active MMP-9 is observed basolaterally and not
apically in polarized lung epithelial cells. To explore the
activation in polarized cells, 16HBE14o or CFBE41o cells
were cultured on semipermeable Transwell filters. These were
infected apically either with B. cenocepacia strain BC7 or with
B. multivorans strain LMG13010, and the filtered conditioned
medium from the apical and basolateral compartments was
analyzed by zymography. No alteration in MMP expression or
activation was observed in the apical supernatants of polarized
16HBE14o cells or CFBE41o cells (data not shown). In
contrast, basolateral levels of activated MMP-9 were increased
following apical infection with B. cenocepacia strain BC7,
which was evident up in the basolateral chamber to 72 h
postinfection in both cell lines (Fig. 4, A and B). Exposure to
B. multivorans strain LMG13010 did not have any apparent
effect on MMP secretion of the lung cell lines, either basolat-
erally or apically on zymograms.
MMPs are not involved in B. cepacia complex-related tight
junction disruption. We and others have previously shown that
coincubation of lung epithelial cells with a series of B. cepacia
complex isolates resulted in disruption of epithelial integrity,
as evidenced by a drop in transepithelial resistance and a
reduction in zonula occludens-1 (ZO-1) expression (9, 25). To
explore whether activation of MMPs were responsible for this
effect, we preexposed polarized CFBE41o cells to the MMP
broad-spectrum inhibitor, GM6001, prior to, and during, infec-
tion with either B. multivorans strain LMG13010, or the B.
cenocepacia strain BC7. The concentration used (10 M) is
recommended for inhibition of a range of MMPs. Exposure of
16HBE14o or CFBE41o cells to these strains resulted in a
drop in TER within 4 h (Fig. 4C), as we have previously
demonstrated for Calu-3 cells. However, inhibition of MMP
activity by incubation with GM6001 prior to and during infec-
tion with B. cepacia complex strains, did not prevent the tight
junction disruption. The drop in TER was comparable with that
of the individual strains without inhibitor in both cell lines.
This clearly indicates that MMPs are unlikely to have any role
in the observed tight junction disruption of B. cepacia com-
plex-infected polarized lung epithelial cells.
MMP-9 slows down wound repair in confluent lung epithelia. To
explore what effect B. cepacia complex activation of MMP-9
has on pathogenesis, the effect of activated MMPs on the
confluent lung epithelial cells was investigated by use of a
wound healing model. Both 16HBE14o (Fig. 5, A and C) and
CFBE41o (Fig. 5, B and D) cells rapidly migrated over the
wound in untreated control conditioned media, albeit the rate
of migration in CFBE41o cells was slower than that of
16HBE14o cells (P  0.05 at later time points 4 to 8 h).
Conditioned medium from B. cenocepacia strain BC7-infected
16HBE14o or CFBE41o cells reduced the rate of wound
repair in both 16HBE14o (P  0.001) and CFBE41o cells
(P  0.05), respectively (Fig. 5). In addition, conditioned
medium from 16HBE14o cells infected with B. multivorans
strain LMG13010 also significantly reduced the rate of wound
repair in 16HBE14o cells (P  0.05), but not in CFBE41o
cells. The apparent difference in the effect of B. multivorans,
which has a weaker effect on MMP-9 activity, on wound repair
may be linked to the slower rate of repair in CFBE41o cells.
In contrast, application of conditioned medium from PAO1-
infected cells (diluted 1:500 to normalize for active gelatinase)
Fig. 2. Expression of MMP genes in response to
B. cepacia complex and P. aeruginosa infection
by real-time PCR. 16HBE14o cells (A) or
CFBE41o cells (B) were infected with B. ceno-
cepacia strain BC7, B. multivorans strain
LMG13010, or P. aeruginosa strain PAO1 for 1
h. MMP-2, MMP-7, and MMP-9 mRNA expres-
sion was determined by real-time quantitative
PCR relative to GAPDH mRNA. A: upregulation
of MMP-2 and MMP-7 mRNA was observed in
response to infection with all 3 species, whereas
MMP-9 upregulation was only observed in re-
sponse to B. cenocepacia. B: MMP-2 and
MMP-9 were both upregulated in response to B.
cenocepacia infection in CFBE41o cells. Bars
represent the average of 3 separate experiments 

SE. *Significant difference in expression from un-
infected cells (P  0.05). **Significant difference
in expression from uninfected cells (P  0.01).
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did not show any effect on the rate of wound repair in either
cell line under the conditions used (Fig. 5).
Specific inhibition of MMP-9 activity was achieved by incu-
bating conditioned cell supernatants with MMP-9 specific inhib-
itor (20 nM), which is four times the reported IC50 value for
MMP-9 inhibition but considerably less than the IC50 values for
its two secondary targets MMP-13 or MMP-1 (IC50 values of 113
nM and 1.05 M, respectively). This concentration was chosen to
ensure complete inhibition of MMP-9 activity. Incubation of
conditioned medium from B. cenocepacia-treated cells with this
inhibitor reduced MMP-9 activity from 4.5 ng/ml (16HBE14o
treated) and 3.3 ng/ml (CFBE41o treated) to undetectable levels
in both cases as determined by MMP-9 fluorometric assay. When
MMP-9 activity was specifically suppressed in conditioned me-
dium from B. cenocepacia-infected cells, the delay in wound
repair that had been observed was reversed and the wound repair
was comparable with that of controls for both cell lines (Fig. 6,
P  0.05). For further confirmation of the role of MMP-9,
conditioned media from control monolayers were also treated
with 1 mM APMA, a potent activator of MMPs. Zymography
verified that there was clear activation of MMP-9 and to a lesser
extent MMP-2 in these conditioned media following APMA
treatment (Fig. 7A). APMA-treated conditioned media applied to
wounded cells also inhibited cell migration and wound repair in
both cell lines (Fig. 7, B and C; P  0.01, in both cases), again
indicating that the presence of activated MMP-9 prevented epi-
thelial wound repair, rather than an alternative bacterial compo-
nent.
Fig. 3. B. cenocepacia infection increases
MMP-9 activity in both cystic fibrosis (CF) and
non-CF lung epithelial cells. 16HBE14o or
CFBE41o cells were treated with bacteria-free
medium (CTRL), B. cenocepacia strain BC7, B.
multivorans strain LMG13010, or P. aeruginosa
strain PAO1, for 24 and 48 h. A: representative
gelatin zymograms of conditioned media from
B. cepacia complex-infected cells and corre-
sponding MMP-9 densitometry. Activation of
MMP-9 but not MMP-2 was observed com-
pared with control. Densitometry data (solid
bars, 16HBE14o; shaded bars, CFBE 41o)
represent the average of 3 separate experiments
and are graphed 	 SE. Act, activated. *Signif-
icant difference in expression from uninfected
cells (P  0.05). B: MMP-9 activity in
16HBE14o (solid bars) and CFBE41o
(shaded bars) 48 h after exposure to B. cepacia
complex or P. aeruginosa as determined by
fluorometric assay (*P  0.05, **P  0.005).
Data represent means of 3 independent experi-
ments 	 SD. C and D: representative zymo-
gram showing that 16HBE14o cells and
CFBE41o cells treated with P. aeruginosa
strain PAO1 secreted high levels of MMP ac-
tivity, which required dilution to below 1:100 to
observe that the predominant activated MMP
was MMP-2. Representative zymograms of 3
independent experiments are shown.
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B. cenocepacia has been established as the most virulent of
all the B. cepacia complex species identified (31, 32), being
more frequently associated with cepacia syndrome and patient
deaths relative to other species in the complex (22). B. ceno-
cepacia also elicits a potent proinflammatory response. Studies
have shown that B. cepacia complex LPS can elicit up to 10
times more TNF- and promote more neutrophil burst com-
pared with LPS from other CF pathogens including P. aerugi-
nosa (19, 36, 52). MMPs are widely implicated in airway
damage in chronic pulmonary diseases including CF; however,
the role of MMPs in the pathogenesis of B. cepacia complex
infection has not been examined to date.
The potential for B. cepacia complex infection to affect
MMP expression was examined by semiquantitative PCR ini-
tially to screen for the upregulation over a wider time frame
and include four MMPs. Upregulation of MMP-2 and MMP-9
genes was evident following infection with both B. cepacia
complex strains and with P. aeruginosa; therefore quantitative
analysis was carried out on both of these genes together with
MMP-7, which has previously been shown to be upregulated in
response to P. aeruginosa. To focus on the early effects of
infection, real-time PCR analysis was carried out on cells at 1
h postexposure to bacteria. This confirmed the upregulation of
the MMP-2, -7 and -9 genes in response to BC7 infection in
16HBE14o cells. MMP-2 and MMP-9 were also upregulated
in the CFBE41o cells within 1 h. Interestingly, the CFTR-
expressing 16HBE14o cells were generally more responsive
to infection from all three species than the CFBE41o cells. In
particular, MMP-7 gene upregulation was not observed in
response to infection with any of the bacteria examined in the
CFBE41o cells within 1 h. MMP-7 is widely reported to be
upregulated in response to P. aeruginosa expression; however,
all the studies have been carried out in CFTR-expressing cells
Fig. 4. Basolateral secretion of active MMP-9 from polarized lung epithelial cells and lack of effect of MMPs on tight junction integrity. A: representative gelatin
zymograms of conditioned media from basolateral chamber of polarized 16HBE14o and CFBE41o cells 48 and 72 h after infection with B. multivorans strain
LMG13010 or B. cenocepacia strain BC7. B: corresponding densitometry. *Significant change in MMP-9 activity (P  0.05). C: inhibition of MMP activity
does not impair B. cepacia complex-induced opening of tight junctions. Polarized 16HBE14o and CFBE41o cells were treated with GM6001 before and
during infection with B. multivorans LMG13010 or B. cenocepacia BC7 and tight junction integrity was monitored by transepithelial electrical resistance (TER),
demonstrating that MMP inhibition does not alter tight junction integrity. Data are presented as % change in TER relative to medium treated control 	 SE from
3 independent experiments.
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Fig. 5. Effects of bacterial infection on wound
repair in lung epithelial cells. Confluent lung
epithelial cells were grown for 24 h and sub-
jected to scrape wounding and allowed to re-
cover over time at 37°C and 5% CO2 in the
presence of conditioned media from control
cells or from cells infected with B. cenocepacia
(BC7), B. multivorans (LMG13010), or P.
aeruginosa (PAO1). A and B: representative
phase-contrast images of 16HBE14o (A) and
CFBE41o (B) cells were captured at 0, 2, 4,
6, and 8 h postwounding to illustrate recovery.
A delay in recovery was evident in cultures
exposed to conditioned media from B. cenoce-
pacia BC7-infected cells. C: migration of
16HBE14o cells over the wound was mea-
sured at hourly intervals and plotted against
time. D: migration of CFBE41o cells over
the wound was measured at hourly intervals
and plotted against time. Data in C and D are
graphed 	 SE and are representative of 3
independent experiments in each case. Signif-
icant difference wound closure following ex-
posure to conditioned medium from infected
cells relative to uninfected cells: **P  0.01,
*P  0.05.
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or tissues (24, 30). To the best of our knowledge, no study has
been carried out to examine the effect of P. aeruginosa on
MMP-7 expression in cells or tissues with a CF phenotype. It
is possible that the MMP-7 upregulation in response to P.
aeruginosa is CFTR dependent or is slower in cells with a CF
phenotype and so should be examined further.
Because of the consistent early upregulation of MMP-2 and
MMP-9 genes in both cell lines, with and without a CF
phenotype, we focused on the gelatinases for further study.
Clear activation of MMP-9 but not MMP-2 in response to B.
cenocepacia exposure was evident in gelatinase zymography.
In addition, we have established that the activation of MMP-9
is polarized and is exclusive to the basolateral side of
CFBE41omonolayers. This is significant because basolateral
activation will have most impact on lung tissue following
infection, having greater access to the basement membrane
components and immune cells. Although the gelatinase activity
following B. cenocepacia infection was much less than that
following P. aeruginosa infection, the predominant gelatinase
activated following P. aeruginosa infection was MMP-2. The
activation of MMP-2 in response to P. aeruginosa strain PAO1
exposure has previously been shown, although exposure of
human airway epithelial cells to supernatants from P. aerugi-
nosa strain PAO1 (1% dilution) did not result in any change in
the expression of MMP-9 or MMP-2 genes (7). Our observed
upregulation of MMP-2 gene expression is probably due to the
fact that we used whole cells, rather than supernatants.
We have previously shown that when B. cenocepacia strain
BC7 or B. multivorans strain LMG13010 was applied to
polarized epithelial cells, the tight junctions were disrupted
with concomitant degradation of the tight junction protein
ZO-1 (9). Given previous reports relating MMP-9 having
activity on the epithelial tight junction protein claudin 1 and
subsequent effects on tight junction integrity, we therefore
wanted to examine whether MMPs were involved in this
previously observed disruption of TER following B. cepacia
complex infection. TER is a widely used marker of tight
junction integrity, one of several indicators of epithelial barrier
disruption. Exposure of polarized 16HBE14o or CFBE41o
cells to either B. cenocepacia strain BC7 or B. multivorans
strain LMG13010, in the presence of GM6001, a broad-
spectrum inhibitor of MMPs-1, -2, -3, -7 and -9 (1, 14), did not
have any effect on tight junction integrity. This suggests that
the observed MMP-9 activation following B. cepacia complex
infection, or any other inhibited MMPs, did not play a role in
this response. The ability for MMPs including MMP-7 and
MMP-9 to degrade tight junction and adherens junction pro-
teins has been shown previously. Asahi et al. (2) have sug-
gested that the tight junction protein ZO-1 is a substrate for
MMP-9 in a blood-brain barrier model. They showed that
Fig. 6. Inhibition of MMP-9 activity in condi-
tioned medium from B. cenocepacia-infected
cells reverses the delay in wound repair. Con-
fluent lung epithelial cells were grown for 24 h
and subjected to scrape wounding and allowed
to recover over time at 37°C and 5% CO2 in the
presence of conditioned media from control
cells or from cells infected with B. cenocepacia
(BC7) in the absence or presence of MMP-9
inhibitor I. A and B: zymography illustrating the
inhibition of MMP-9 activation in 16HBE14o
cells (A) and CFBE41o cells (B) in the pres-
ence of MMP-9 inhibitor 1. C and D: represen-
tative phase-contrast images of 16HBE14o
(A) and CFBE41o (B) cells were captured at
0, 4, and 8 h postwounding to illustrate recov-
ery. The delay in recovery evident in cultures
exposed to conditioned media from B. cenoce-
pacia strain BC7-infected cells was reversed in
cultures exposed to conditioned medium from
B. cenocepacia strain BC7-infected cells in the
presence of MMP-9 inhibitor I. E: migration of
16HBE14o cells over the wound was mea-
sured and plotted against time. F: migration of
CFBE41o cells over the wound was measured
and plotted against time. Data in E and F are
graphed 	 SE and are representative of 3 inde-
pendent experiments in each case. Significant
difference wound closure following exposure to
conditioned medium from infected cells relative
to uninfected cells: *P  0.05.
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ZO-1 degradation, but not occludin degradation, during cere-
bral ischemia was reduced in MMP-9/ mice relative to wild
type. However, this is a complex model, and many other
explanations for this exist. Harkness et al. (17) used confocal
microscopy to demonstrate that MMP-9 caused subtle changes
in the expression of ZO-1 in the rat endothelium of the central
nervous system. In contrast, Ichiyasu et al. (20) have demon-
strated that the absence of MMP-9 in knockout mice increased
levels of the tight junction regulatory protein, claudin-1, with a
concomitant drop in transepithelial migration of dendritic cells.
The tight junctions are very tightly regulated, and the degra-
dation of one tight junction protein in isolation cannot be
conclusive regarding the integrity of the tight junction complex
as a whole. An important feature of tight junctional regulation
is that other junctional proteins can compensate for the degra-
dation or lack of a single protein (33). It is clear from our data
that MMPs do not contribute to the disruption of tight junctions
associated with B. cepacia complex infection.
A delay in wound repair was observed in cells treated with
conditioned medium from both cell lines infected with B.
cenocepacia and with conditioned medium from B. multiv-
orans-infected 16HBE41o cells. The finding that specific
inhibition of MMP-9 completely reversed this delay in wound
repair in both cell lines following B. cenocepacia infection
strongly suggests that MMP-9 is responsible for the delay in
wound repair following B. cenocepacia infection. The lack of
Fig. 7. 4-Aminophenylmercuric acetate (APMA) activation of conditioned medium from uninfected cells results in MMP-9 activation and consequent delay in
wound repair. Confluent lung epithelial cells were grown for 24 h and subjected to scrape wounding and allowed to recover over time at 37°C and 5% CO2 in
the presence of conditioned media from control cells with or without APMA pretreatment. A: zymogram of conditioned media from confluent epithelial cells
exposed to control medium only (MEM), following exposure to the vehicle only (DMSO) or exposed to APMA. B: representative phase-contrast images of
16HBE14o and CFBE41o cells were captured at 0, 2, 4, 6, and 8 h postwounding to illustrate recovery. A delay in recovery was evident in both 16HBE14o
and CFBEo cultures exposed to conditioned media treated with APMA. C: migration of 16HBE14o cells over the wound was measured at hourly intervals
and plotted against time. D: migration of CFBE41o cells over the wound was measured at hourly intervals and plotted against time for control cells and those
exposed to APMA (or DMSO only)-treated conditioned medium. Data in C and D are graphed	 SE and are representative of 3 independent experiments in each
case. *Significant difference wound closure following exposure to conditioned medium following APMA treatment relative to control conditioned media (P 
0.01).
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a delay in wound repair in CFBE41o cells exposed to
conditioned medium from B. multivorans exposed cells, de-
spite a twofold increase in MMP-9 activity, was unexpected
but may relate to the overall slower repair in this particular cell
line. A delay in wound repair may have become apparent over
a longer period of time. MMPs have been associated both with
tissue destruction and with tissue repair (38–40). Olsen et al.
(38) have recently demonstrated that exposure of 16HBE14o
cells to arsenic upregulated both MMP-9 expression and ac-
tivity. No alteration in MMP-2 activity was observed. Consis-
tent with our data, the activation of MMP-9 correlated with an
impairment of wound repair in confluent monolayers of lung
epithelial cells. In addition to delayed wound repair, it is likely
that MMP-9 activation may further exacerbate the host re-
sponse to B. cepacia complex infection. It has been shown that
high levels of MMP-9 promote infiltration of inflammatory
cells and exacerbate the symptoms of asthma (26). In addition,
MMP-9 upregulation and activation is expressed during vari-
ous stages of tuberculosis infection including the tuberculous
granuloma, where it is associated with tissue destruction (41).
MMP-9 expression was also induced in vivo in mice infected
with another respiratory pathogen, Francisella tularensis, and
was demonstrated to play a clear role in pathogenesis of this
infection, in terms of histopathology, neutrophil recruitment,
and proinflammatory response (34). Exposure of 16HBE14o
cells to supernatants or mucopurulent material from CF air-
ways upregulated a number of MMP genes, including MMP-9
but not MMP-2 (42). This effect was downregulated in re-
sponse to azithromycin. Further roles in proinflammatory ac-
tivity of MMP-9 have been demonstrated: MMP-9 processing
of the proinflammatory cytokine IL-8 has been shown to
increase its chemotactic activity (46, 47) and MMP-9 has been
shown to activate IL-1 precursor, another mediator of the
inflammatory response (21). Gaggar et al. (12) have shown that
MMP-9 is involved in a proteolytic cascade that generates the
neutrophil chemoattractant proline-glycine-proline (PGP) from
collagen, and this peptide is substantially upregulated in CF
sputum samples. The further upregulation of MMP-9 in B.
cenocepacia-colonized patients is likely to further contribute to
elevated PGP levels and the subsequent chronic inflammatory
response.
MMP-9 levels have also been implicated with poor survival
in P. aeruginosa pneumonia non-CF patients (10). Bronchoal-
veolar lavage (BAL) fluid taken from surviving ventilator-
associated pneumonia patients had a lower ratio of MMP-9 to
TIMP relative to those that died. In addition, MMP-9 levels
progressively declined in patients= BAL in response to antibi-
otic therapy (10). MMP-9 activity was also elevated in sputa
from lung transplant patients, and those with the highest levels
of MMP-9 activity were associated with patients with chronic
lung transplant rejection (5). Transplanted CF patients that
have been colonized with B. cenocepacia have poorer progno-
sis compared with patients colonized with other members of
the complex (8). The activation of MMP-9 in response to B.
cenocepacia infection together with its likely role in lung
damage, shown here, may provide one mechanism whereby B.
cenocepacia-colonized patients have poorer outcomes on
transplant than patients colonized by B. cepacia complex
species other than B. cenocepacia and is worthy of further
study.
The activation of MMP-9, together with the observed delay
in wound repair in CFTR-expressing cells following infection
with B. multivorans strain LMG13010, may have relevance for
patients with CGD. B. multivorans is the most frequently
isolated species among CGD patients (13). Furthermore, it was
recently shown that B. multivorans associated more with cells
from CGD patients than from healthy donors, and infection
was associated greater levels of proinflammatory cytokines
(51). Our data show that MMP-9 activation may also play a
role in delayed the repair of lung damage in addition to a role
in the inflammatory response in these patients.
In summary, previous studies have shown that the expres-
sion of MMP-9 is enhanced in human airway CF epithelium
relative to non-CF epithelia and elevated in serum of CF
patients and correlated with pulmonary exacerbations (16, 43).
The further activation of MMP-9 in response to B. cenocepacia
infection and its effect on delaying epithelial repair, as dem-
onstrated here, would contribute to chronic lung damage that is
a key feature of CF lung disease and it is likely to further
exacerbate inflammation in B. cenocepacia-colonized patients.
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